- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
Pence wants $1.5M a year for life sciences institute
January 21, 2013
J.K. WallThe Indiana Applied Research Enterprise already has received support from John Lechleiter, CEO of Indianapolis-based Eli Lilly
and Co., as a place for collaboration between academic and industrial scientists.
MoreFormer state ag director joins Dow AgroSciences
January 21, 2013
Joseph Kelsay, who had served as director of Indiana's Department of Agriculture since 2009, is joining Dow AgroSciences'
government affairs team as senior manager of biotechnology affairs.
MoreBioCrossroads seed fund makes first investments
January 10, 2013
Local startups Esanex Inc. and Algaeon Inc. have received $500,000 and $250,000, respectively, from Indiana Seed Fund II,
BioCrossroads' second fund to help fledgling life sciences companies.
MoreIEDC seeks $30M fund to stoke life sciences firms
December 15, 2012
Kathleen McLaughlinThe Indiana Economic Development Corp. is looking to renew its commitment to life sciences by creating a $30 million venture
fund. The amount dedicated to one sector would be equal to the state’s allocation for all high-tech startups over the
past two years.
MoreNico raises $6.5 million more from existing investors
December 4, 2012
J.K. WallIndianapolis-based Nico Corp. wants to use its new round of capital to develop brain surgery products to address diseases
that were often considered inoperable, such as metastatic brain cancer and intracerebral hemorrhages.
MoreCancer treatment firm adding 27 jobs in Indianapolis
December 3, 2012
J.K. WallA North Carolina-based maker of cancer-fighting ultrasound machines plans to create 27 jobs paying an average of $36 an hour
at its Indianapolis facility over the next three years.
MoreVC funds hope to help early-stage life sciences firms
December 1, 2012
J.K. WallEarly-stage venture capital has been harder and harder to come by for life sciences companies in recent years, but two Indianapolis
investors are working to raise sizable funds to help fill the gap.
MoreCook wins approval for new stent
November 19, 2012
J.K. WallBloomington-based Cook Medical won approval for the first drug-coated stent for clogged leg arteries in the United States,
which accounts for 40 percent of the soon-to-be $3 billion market.
MoreIndy loses promising health startup
November 12, 2012
J.K. WallLabDoor, which soon will launch an iPhone app that assigns A-F grades to over-the-counter vitamins and medicines, moved last
month from Indianapolis to San Francisco, where it received $100,000 in startup financing.
MoreLocal scientific software firm plans to add 63 jobs
November 12, 2012
Scott OlsonIndianapolis-based Indigo Biosystems Inc., a scientific software provider, announced Monday morning that it plans to add 63
jobs by 2015 as part of a $1.4 million expansion.
MoreLife sciences finance pro heading to startup
November 10, 2012
Chris O'MalleyIf a biotech startup were akin to a rock band, Kristin Sherman might be the keyboardist. She’s not front-and-center
on the stage, but the ballad wouldn’t be as dynamic without her pounding the chords.
MoreCommunity to commercialize innovations
November 5, 2012
J.K. WallCommunity Health Network thinks it can help patients, engage doctors and maybe even make some money by trying to turn ideas
within its organization into commercial products, service and companies.
MoreLife sciences logistics firm plans to add 108 workers
November 5, 2012
Scott OlsonIndianapolis-based BioStorage Technologies Inc. is planning to add 108 jobs in the next five years as part of a $7 million
expansion and is seeking financial incentives from the city for the second time in three years.
MoreLife sciences leader juggles faith, science and business
November 3, 2012
J.K. WallBioCrossroads CEO David Johnson sees little conflict as he balances all three in promoting and investing in Indiana life sciences
firms
MorePurdue researcher harbors high hopes for new venture
November 3, 2012
Scott OlsonPete Kissinger hopes Phlebotics will follow in the footsteps of another of his creations, Bioanalytical Systems Inc.
MoreLilly to spend $140M on new insulin cartridge plant
November 1, 2012
J.K. WallAbout 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But
only “some” of that number will be new hires.
MoreLilly plans expansion of local insulin plant
October 30, 2012
J.K. WallThe Indianapolis-based drugmaker plans to expand its local insulin plants to make insulin cartridges to meet what it describes
as growing demand in the United States.
MoreOutlook gloomy for device investments
October 29, 2012
J.K. WallThe amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this
year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association
and PricewaterhouseCoopers.
MoreProfit falls at Dow AgroSciences even as sales rise
October 24, 2012
J.K. WallStrong demand from farmers boosted sales by 8 percent at Dow AgroSciences LLC in the third quarter, but continued investments
in new technologies slashed profits by 16 percent.
MoreLilly CEO calls for life sciences research institute
October 23, 2012
J.K. WallEli Lilly CEO John Lechleiter on Tuesday called for creation of a "world-class" research institute in Indianapolis to bring
together scientists from universities and corporations to develop new medical therapies and companies.
MoreRoche continues to restructure diabetes unit
October 22, 2012
J.K. WallRoche officials said last week that price competition and lower reimbursement rates are forcing it to make an unspecified
number of cuts in its U.S. sales force and at its research and development hubs in Indianapolis and Germany.
MoreDANZ: Indianapolis tech community should build momentum
October 20, 2012
Kristine Danz / Special to IBJMore money, mentoring would add fuel to lively industry.
MoreIndianapolis tech firms, hospitals discover mutual need
October 20, 2012
Chris O'MalleyAn initiative is matching tech entrepreneurs with hospital officials in the hope of solving health care problems.
MoreLilly stomach-cancer drug helps survival, study finds
October 15, 2012
Bloomberg NewsEli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer
drug helped patients with advanced disease live longer.
MoreEvans to lead AIT again as CEO leaves company
October 15, 2012
IBJ StaffRon Thieme, who took over as president and CEO of AIT Laboratories during a management shakeup earlier this year, is leaving
the company, the Indianapolis-based firm announced Monday morning.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
First, the Athenaeum is going to have to get past the hurdle with the Lockerbie residents and the agreement that the parcel would be residential. Second, and in my opinion, this prime piece of property should include parking, PLUS, a black box theater(s), some market rate and affordable artist housing and a plan to renovate and reconfigure the second story theater. I would negotiate to add the DeHaan property surface parking lot into the development mix, place a one story surface parking garage on the DeHaan lot on the street level (for the Dehaan tenants use during the daytime) and add a second story to the garage that would become an addition to the current second story theater and then change the direction of the theater by moving the stage across the alley and on top of the DeHaan lot parking. You can add all the stage elements that are currently missing from the Athenaeum stage to make it more attractive for use by Ballet, Opera and traveling productions. Plus, the theater changes would probably help solve some of the soundproofing issues. Alas,it does not seem to be a part of the strategic plan to conduct a study to determine best use of the property. Seems like the current plan is a quick and easy move that ignores the property best use/potential and any strategic property planning for the effect on future generations.
I recall that MSA's pilings are still in the ground and hard to remove. It’s not likely any proposal will include significant underground construction/parking because of this. Start adding 2 floors of retail, 8 floors of parking and 5-10 floors of possible hotel, and/or 10-20 floors of residential, and you are at 30 floors already with possible expansion of all the uses. But then again I could be wrong.
Accoriding to their website there is no deadline to the Do Not Call list. What is this article referring to??
On what planet are they entitled to this largesse from the stockholders? These people make multi-million dollar salaries: Pay for your own personal travel.
It matters because they're already paid enormously fat salaries: Pay for your own personal travel. Being "taxed on it" isn't a valid excuse--so what? They're still being gifted a raft of luxury perks from somebody else's money on top of an enormous, lavish salary.